Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Study backs LimFlow system for treating chronic limb-threatening ischemia

By

LimFlow system treating chronic limb-threatening ischemia
The LimFlow System turns a vein into an artery to deliver blood flow down to an ischemic foot. This aims to prevent amputation, relieve pain and promote wound healing in patients with CLTI. [Image courtesy of LimFlow]
LimFlow announced that new study results demonstrated statistically significant survival with its chronic limb-threatening ischemia (CLTI) treatment.

Paris-based LimFlow’s results came from its Promise II U.S. pivotal trial. They were published in today’s issue of the New England Journal of Medicine (NEJM). Data demonstrated 66% amputation-free survival at six months with the LimFlow system.

Get the full story at our sister site, MassDevice.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.